Edition:
India

Evotec AG (EVTG.DE)

EVTG.DE on Xetra

12.39EUR
17 Nov 2017
Change (% chg)

€-0.43 (-3.32%)
Prev Close
€12.81
Open
€12.70
Day's High
€12.92
Day's Low
€12.12
Volume
3,490,494
Avg. Vol
1,901,753
52-wk High
€22.50
52-wk Low
€5.67

Chart for

About

Evotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical fee-for-service basis or integrated drug discovery collaborations on partners' target through a range of commercial structures, including research fees,... (more)

Overall

Beta: 0.67
Market Cap(Mil.): €3,115.81
Shares Outstanding(Mil.): 147.49
Dividend: --
Yield (%): --

Financials

BRIEF-Evotec affirms guidance after 9-month core profit jump

* ‍9M adjusted group EBITDA up 28% to eur 39.3 m (9m 2016: eur 30.6 m)​

08 Nov 2017

BRIEF-Evotec, Tesaro enter partnership on novel immuno-oncology agents

* dgap-news: evotec and tesaro enter strategic partnership to discover novel immuno-oncology agents

26 Oct 2017

BRIEF-Evotec achieves first milestone in neurodegeneration alliance with Celgene​‍​

* ‍Evotec achieves first milestone in neurodegeneration alliance with Celgene​

10 Oct 2017

BRIEF-Evotec receives $5 million milestone in Celgene alliance

* Says ‍announced today that its strategic alliance with celgene has reached a first milestone triggering revenues of $ 5.0 m to evotec, which are recognised in q3 of 2017​ Source text for Eikon: Further company coverage: (Frankfurt newsroom)

10 Oct 2017

BRIEF-Evotec says invests in Exscientia to advance AI-driven drug discovery

* Says Evotec invests in Exscientia to advance AI-driven drug discovery

28 Sep 2017

BRIEF-Evotec: EIB grants Evotec unsecured loan facility of up to EUR 75 mln

* DGAP-NEWS: EUROPEAN INVESTMENT BANK SUPPORTS EVOTEC'S INNOVATE STRATEGY WITH EUR 75 M LOAN

08 Sep 2017

German stocks - Factors to watch on September 7

FRANKFURT, Sept 7 The DAX top-30 index looked set to open 0.6 percent lower on Thursday, according to premarket data from brokerage Lang & Schwarz at 0649 GMT.

07 Sep 2017

BRIEF-Abivax and Evotec enter into strategic collaboration

* ABIVAX AND EVOTEC ENTER INTO STRATEGIC COLLABORATION TO DEVELOP NOVEL ANTIVIRAL AGENTS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

07 Sep 2017

BRIEF-Evotec completes acquisition of Aptuit

* Says completes acquisition of aptuit Source text for Eikon: Further company coverage:

16 Aug 2017

BRIEF-Evotec confirms outlook after H1 core profit jump

* Group revenues: 37% increase to eur 103.4 m (h1 2016: eur 75.5 m);

10 Aug 2017

Earnings vs. Estimates